What is the enterprise value (EV) for PharmaCyte Biotech, Inc. (PMCB)?

The enterprise value (EV) for PMCB stock is $-14.21M.

PharmaCyte Biotech (PMCB) Enterprise Value: History & Chart

Compare

PharmaCyte Biotech, Inc.(PMCB)

Biotechnology · Las Vegas, NV

$0.41+0.02 (+5.02%)

Delayed quote: Oct 6, 2026, 12:41 PM EDT

Compare

About PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc. is a biotechnology firm dedicated to the development and commercialization of advanced cellular therapies within the United States. Their primary therapeutic areas include various forms of cancer, diabetes, and malignant ascites. Central to their efforts is Cell-in-a-Box, their proprietary encapsulation technology which utilizes cellulose to enclose live cells. This innovative platform serves as the foundation for treatments aimed at diverse cancers, such as advanced and inoperable pancreatic cancer, as well as diabetes. The company's pipeline includes therapies for pancreatic and other solid cancerous tumors; a treatment for Type 1 and insulin-dependent Type 2 diabetes involving encapsulated, genetically modified insulin-producing cells; and cancer treatments derived from cannabis plant compounds. To further its research, PharmaCyte maintains collaborative agreements: one with the University of Technology, Sydney, for the creation of melligen cells to combat diabetes, and another with the University of Northern Colorado, focusing on methods for identifying, separating, and quantifying cannabis constituents. Originally established in 1996, the company operated under the name Nuvilex, Inc. before rebranding as PharmaCyte Biotech, Inc. in January 2015. Its corporate headquarters are located in Las Vegas, Nevada.

Las Vegas, NV

2 employees

pharmacyte.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Joshua N. Silverman

View full financials

NAME	MARKET CAP	ENTERPRISE VALUE (EV)
PharmaCyte Biotech, Inc. (PMCB)	$4.40M	$-14.21M
CollPlant Biotechnologies Ltd. (CLGN)vs ›	$4.43M	$4.14M
Dermata Therapeutics, Inc. (DRMA)vs ›	$4.52M	$112147.00
20/20 Biolabs Inc. (AIDX)vs ›	$4.21M	$237044.00
60 Degrees Pharmaceuticals, Inc. (SXTP)vs ›	$4.19M	$3.31M
CalciMedica, Inc. (CALC)vs ›	$4.63M	N/A
Bio Green Med Solution, Inc. (BGMS)vs ›	$4.64M	$851862.00
GRI Bio, Inc. (GRI)vs ›	$4.15M	N/A
Processa Pharmaceuticals, Inc. (PCSA)vs ›	$4.10M	$3.90M
Aptevo Therapeutics Inc. (APVO)vs ›	$4.00M	N/A

NAME

MARKET CAP

ENTERPRISE VALUE (EV)

PharmaCyte Biotech, Inc. (PMCB)

$4.40M

$-14.21M

CollPlant Biotechnologies Ltd. (CLGN)vs ›

$4.43M

$4.14M

Dermata Therapeutics, Inc. (DRMA)vs ›

$4.52M

$112147.00